Bank Of The West Bristol Myers Squibb CO Transaction History

Bank Of The West

$851 Million
Q4 2022

A detailed history of Bank Of The West transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bank Of The West holds 51,129 shares of BMY stock, worth $2.87 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

51,129

Previous 44,156 15.79%

Holding current value

$2.87 Million

Previous $3.14 Million 17.17%

% of portfolio

0.43%

Previous 0.41%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	BUY	$68.48 - $81.09 $477,511 - $565,440	6,973 Added 15.79%	51,129 $3.68 Million
Q3 2022 Oct 31, 2022	BUY	$0.13 - $76.84 $127 - $75,456	982 Added 2.27%	44,156 $3.14 Million
Q2 2022 Aug 02, 2022	BUY	$72.62 - $79.98 $320,689 - $353,191	4,416 Added 11.39%	43,174 $3.33 Million
Q1 2022 Apr 22, 2022	SELL	$61.48 - $73.72 $35,904 - $43,052	-584 Reduced 1.48%	38,758 $2.83 Million
Q4 2021 Jan 28, 2022	SELL	$53.63 - $62.52 $3.8 Million - $4.43 Million	-70,817 Reduced 64.29%	39,342 $2.45 Million
Q3 2021 Nov 09, 2021	BUY	$59.17 - $69.31 $228,573 - $267,744	3,863 Added 3.63%	110,159 $6.52 Million
Q2 2021 Aug 11, 2021	BUY	$61.91 - $67.42 $1.39 Million - $1.52 Million	22,489 Added 26.83%	106,296 $7.1 Million
Q1 2021 May 10, 2021	BUY	$59.34 - $66.74 $247,922 - $278,839	4,178 Added 5.25%	83,807 $5.29 Million
Q4 2020 Feb 02, 2021	BUY	$57.74 - $65.43 $457,878 - $518,859	7,930 Added 11.06%	79,629 $4.94 Million
Q3 2020 Nov 05, 2020	BUY	$57.43 - $63.64 $957,932 - $1.06 Million	16,680 Added 30.32%	71,699 $4.32 Million
Q2 2020 Aug 10, 2020	BUY	$54.82 - $64.09 $157,662 - $184,322	2,876 Added 5.52%	55,019 $3.24 Million
Q1 2020 May 08, 2020	SELL	$46.4 - $67.43 $16,750 - $24,342	-361 Reduced 0.69%	52,143 $2.91 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $447,564 - $583,808	9,095 Added 20.95%	52,504 $3.37 Million
Q3 2019 Oct 28, 2019	BUY	$42.77 - $50.71 $1.01 Million - $1.2 Million	23,671 Added 119.93%	43,409 $2.2 Million
Q2 2019 Jul 18, 2019	SELL	$44.62 - $49.34 $1,829 - $2,022	-41 Reduced 0.21%	19,738 $895,000
Q1 2019 Apr 09, 2019	BUY	$45.12 - $53.8 $21,747 - $25,931	482 Added 2.5%	19,779 $943,000
Q4 2018 Feb 07, 2019	SELL	$48.76 - $63.23 $9,118 - $11,824	-187 Reduced 0.96%	19,297 $1 Million
Q3 2018 Nov 02, 2018	SELL	$55.19 - $62.25 $42,882 - $48,368	-777 Reduced 3.83%	19,484 $1.21 Million
Q2 2018 Jul 25, 2018	SELL	$50.53 - $62.98 $18,392 - $22,924	-364 Reduced 1.76%	20,261 $1.12 Million
Q1 2018 May 08, 2018	BUY	$59.92 - $68.98 $3,535 - $4,069	59 Added 0.29%	20,625 $1.3 Million
Q4 2017 Feb 05, 2018	SELL	$59.94 - $65.35 $5,094 - $5,554	-85 Reduced 0.41%	20,566 $1.26 Million
Q3 2017 Oct 17, 2017	BUY	$55.23 - $63.74 $1.14 Million - $1.32 Million	20,651	20,651 $1.32 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of The West, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of The West with notifications on news.

Account